Literature DB >> 7739890

In vivo footprinting and functional analysis of the human c-sis/PDGF B gene promoter provides evidence for two binding sites for transcriptional activators.

R P Dirks1, H J Jansen, B van Gerven, C Onnekink, H P Bloemers.   

Abstract

By in vivo DMS footprint and reporter gene analyses we identified two transcription factor binding sites in the human c-sis/PDGF B gene promoter. The low basal activity of the PDGF B promoter in HeLa and undifferentiated K562 cells, which express low PDGF B mRNA levels, and in PC3 cells, which express a high PDGF B mRNA level, results from binding of a weak transcriptional activator between positions -64 and -61 relative to the transcription start site. Cytotrophoblast-like JEG-3 cells, which do not express the 3.5 kb PDGF B mRNA, contain a transcriptional activator directed at the -64/-61 sequence, but DNA methylation may render the endogenous promoter inaccessible to this activator. A CCACCCAC element at position -61/-54 was identified as the in vivo binding site for a strong transcriptional activator in phorbol ester-treated megakaryocytic K562 cells, which express a high PDGF B mRNA level. Primary human fibroblasts, which do not transcribe the PDGF B gene, contain a transcriptional activator that recognizes an element between positions -60 and -45 but does not bind to the endogenous unmethylated promoter. Our results show that the complex expression pattern of the human PDGF B gene involves the cell type-specific expression of weak and strong transcriptional activators and regulation of promoter accessibility to these factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739890      PMCID: PMC306819          DOI: 10.1093/nar/23.7.1119

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  56 in total

1.  Platelet alpha granules contain a growth factor for fibroblasts.

Authors:  D R Kaplan; F C Chao; C D Stiles; H N Antoniades; C D Scher
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

2.  Chromosomal localization of the human homolog (c-sis) of the simian sarcoma virus onc gene.

Authors:  R Dalla-Favera; R C Gallo; A Giallongo; C M Croce
Journal:  Science       Date:  1982-11-12       Impact factor: 47.728

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor.

Authors:  G R Grotendorst; H E Seppä; H K Kleinman; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells.

Authors:  D C Swan; O W McBride; K C Robbins; D A Keithley; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Developmentally regulated production of platelet-derived growth factor-like molecules.

Authors:  R A Seifert; S M Schwartz; D F Bowen-Pope
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Platelet-derived growth factor in chemotactic for fibroblasts.

Authors:  H Seppä; G Grotendorst; S Seppä; E Schiffmann; G R Martin
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.